Phoenix Licensing, L.L.C. et al v. AAA Life Insurance Company, No. 2:13-cv-01081 (E.D. Tex. June 22, 2015)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

On June 4, 2015, the Court held a second hearing to determine the proper construction of the disputed claim terms in United States Patent Nos. 5,987,434 (“the ‘434 Patent”); 6,999,938 (“the ‘938 Patent”); 7,856,375 (“the ‘375 Patent”); 7,860,744 (“the ‘744 Patent”); 7,890,366 (“the ‘366 Patent”); 8,234,184 (“the ‘184 Patent”); 8,352,317 (“the ‘317 Patent”); 8,606,632 (“the ‘632 Patent”); 8,719,114 (“the ‘114 Patent”); and 8,738,435 (“the ‘435 Patent”) (collectively, the “Asserted Patents”).